Uses quantitative MRI and fMRI to measure cerebrovascular function, oxygenation and microstructure, linking brain physiology with cognition across aging and preclinical Alzheimer’s. Combines high‑field imaging, longitudinal cohorts and open datasets to validate biomarkers and mitigate vascular confounds.